JP2023052777A5 - - Google Patents

Download PDF

Info

Publication number
JP2023052777A5
JP2023052777A5 JP2023012476A JP2023012476A JP2023052777A5 JP 2023052777 A5 JP2023052777 A5 JP 2023052777A5 JP 2023012476 A JP2023012476 A JP 2023012476A JP 2023012476 A JP2023012476 A JP 2023012476A JP 2023052777 A5 JP2023052777 A5 JP 2023052777A5
Authority
JP
Japan
Prior art keywords
cells
lymphocytes
polynucleotide
contacting
encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023012476A
Other languages
English (en)
Japanese (ja)
Other versions
JP7631387B2 (ja
JP2023052777A (ja
Filing date
Publication date
Priority claimed from JP2020150411A external-priority patent/JP7267976B2/ja
Application filed filed Critical
Publication of JP2023052777A publication Critical patent/JP2023052777A/ja
Publication of JP2023052777A5 publication Critical patent/JP2023052777A5/ja
Priority to JP2025017444A priority Critical patent/JP2025069383A/ja
Application granted granted Critical
Publication of JP7631387B2 publication Critical patent/JP7631387B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023012476A 2011-04-06 2023-01-31 末梢免疫機能を調節するための方法及び組成物 Active JP7631387B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025017444A JP2025069383A (ja) 2011-04-06 2025-02-05 末梢免疫機能を調節するための方法及び組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161516637P 2011-04-06 2011-04-06
US61/516,637 2011-04-06
US201161541248P 2011-09-30 2011-09-30
US61/541,248 2011-09-30
JP2020150411A JP7267976B2 (ja) 2011-04-06 2020-09-08 末梢免疫機能を調節するための方法及び組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020150411A Division JP7267976B2 (ja) 2011-04-06 2020-09-08 末梢免疫機能を調節するための方法及び組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025017444A Division JP2025069383A (ja) 2011-04-06 2025-02-05 末梢免疫機能を調節するための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2023052777A JP2023052777A (ja) 2023-04-12
JP2023052777A5 true JP2023052777A5 (enExample) 2023-06-16
JP7631387B2 JP7631387B2 (ja) 2025-02-18

Family

ID=47139503

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2014504019A Active JP5932970B2 (ja) 2011-04-06 2012-04-06 末梢免疫機能を調節するための方法及び組成物
JP2016089159A Active JP6134032B2 (ja) 2011-04-06 2016-04-27 末梢免疫機能を調節するための方法及び組成物
JP2017083713A Active JP6392926B2 (ja) 2011-04-06 2017-04-20 末梢免疫機能を調節するための方法及び組成物
JP2018153539A Active JP6981934B2 (ja) 2011-04-06 2018-08-17 末梢免疫機能を調節するための方法及び組成物
JP2020150411A Active JP7267976B2 (ja) 2011-04-06 2020-09-08 末梢免疫機能を調節するための方法及び組成物
JP2023012476A Active JP7631387B2 (ja) 2011-04-06 2023-01-31 末梢免疫機能を調節するための方法及び組成物
JP2025017444A Pending JP2025069383A (ja) 2011-04-06 2025-02-05 末梢免疫機能を調節するための方法及び組成物

Family Applications Before (5)

Application Number Title Priority Date Filing Date
JP2014504019A Active JP5932970B2 (ja) 2011-04-06 2012-04-06 末梢免疫機能を調節するための方法及び組成物
JP2016089159A Active JP6134032B2 (ja) 2011-04-06 2016-04-27 末梢免疫機能を調節するための方法及び組成物
JP2017083713A Active JP6392926B2 (ja) 2011-04-06 2017-04-20 末梢免疫機能を調節するための方法及び組成物
JP2018153539A Active JP6981934B2 (ja) 2011-04-06 2018-08-17 末梢免疫機能を調節するための方法及び組成物
JP2020150411A Active JP7267976B2 (ja) 2011-04-06 2020-09-08 末梢免疫機能を調節するための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025017444A Pending JP2025069383A (ja) 2011-04-06 2025-02-05 末梢免疫機能を調節するための方法及び組成物

Country Status (6)

Country Link
US (6) US8785190B2 (enExample)
EP (1) EP2694080B1 (enExample)
JP (7) JP5932970B2 (enExample)
CN (2) CN106692193B (enExample)
CA (1) CA2832356C (enExample)
WO (1) WO2012154344A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012154344A1 (en) * 2011-04-06 2012-11-15 Sanbio, Inc. Methods and compositions for modulating peripheral immune function
JP6023218B2 (ja) 2012-01-27 2016-11-09 サンバイオ，インコーポレイティド 血管新生及び血管発生を調節するための方法及び組成物
CN109718250B (zh) 2012-05-16 2022-08-30 桑比欧公司 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物
EP2906293B1 (en) 2012-10-09 2018-12-12 SanBio, Inc. Methods and compositions for treatment of retinal degeneration
ES2647494T3 (es) * 2013-03-01 2017-12-21 Apceth Gmbh & Co. Kg Protección del endotelio vascular de las reacciones citotóxicas mediadas inmunológicamente con células progenitoras humanas cd34-negativo
ES2748825T3 (es) * 2013-03-15 2020-03-18 Tigenix S A U Biomarcadores de linfocitos para determinar la respuesta clínica a la terapia celular
US20160095885A1 (en) 2014-10-01 2016-04-07 WibiWorks Therapeutics, Inc. Induction Medium & Methods for Stem Cell Culture & Therapy
CN105985928A (zh) * 2015-02-10 2016-10-05 睿尔（天津）生物科技有限公司 一种增强间充质干细胞免疫调节能力的预处理培养方法
CA2977106A1 (en) * 2015-02-27 2016-09-01 Icell Gene Therapeutics Llc Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof
CN106148276A (zh) * 2015-04-16 2016-11-23 中国科学院上海生命科学研究院 间充质干细胞在制备治疗神经退行性疾病的药物中的应用
CN107847657A (zh) * 2015-06-15 2018-03-27 生命治疗有限公司 用于诱导抗炎反应的组合物和方法
US11173179B2 (en) 2015-06-25 2021-11-16 Icell Gene Therapeutics Llc Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof
TWI833684B (zh) 2015-06-25 2024-03-01 美商生物細胞基因治療有限公司 嵌合抗原受體（ｃａｒ）、組合物及其使用方法
US10383895B2 (en) * 2016-02-18 2019-08-20 Viera Bioscience, Inc. Stimulation of therapeutic angiogenesis by T regulatory cells
US11534496B2 (en) 2016-06-07 2022-12-27 The Brigham And Women's Hospital, Inc. Compositions and methods relating to T peripheral helper cells in autoantibody-associated conditions
CN109562126A (zh) 2016-06-24 2019-04-02 美商生物细胞基因治疗有限公司 嵌合抗原受体(car)、组合物及其使用方法
WO2018125829A1 (en) 2016-12-28 2018-07-05 Sanbio, Inc. Cell delivery system and methods of operation thereof
CN118853581A (zh) 2017-06-21 2024-10-29 美商生物细胞基因治疗有限公司 嵌合抗原受体(CARs)、组合物及其使用方法
WO2021075525A1 (ja) 2019-10-17 2021-04-22 テルモ株式会社 炎症性疾患を処置するための細胞培養物
CN111979186B (zh) * 2020-08-21 2022-04-08 遵义医科大学附属医院 一种快速高效体外扩增人间充质干细胞的方法及应用
CN116376828B (zh) * 2023-06-02 2023-08-11 成都云测医学生物技术有限公司 一种诱导CD4+T细胞生成Treg细胞的方法及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5932970Y2 (ja) 1979-09-29 1984-09-14 トキナ−光学株式会社 ズ−ム式交換レンズにおける焦点距離の表示装置
JPS5993639U (ja) 1982-12-11 1984-06-25 愛知電機株式会社 撹拌装置における内容物の自動排出，投入装置
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
EP1616958A3 (en) * 1996-11-07 2006-02-08 Lorantis Limited Notch-ligands for use in immunotherapy
US6280718B1 (en) 1999-11-08 2001-08-28 Wisconsin Alumni Reasearch Foundation Hematopoietic differentiation of human pluripotent embryonic stem cells
US6602711B1 (en) 2000-02-21 2003-08-05 Wisconsin Alumni Research Foundation Method of making embryoid bodies from primate embryonic stem cells
US7005252B1 (en) 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US20030003090A1 (en) 2001-05-31 2003-01-02 Prockop Darwin J. Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
EP1410018A1 (en) * 2001-07-25 2004-04-21 Lorantis Limited Method for detecting modultators of notch signalling
US6887706B2 (en) 2001-10-03 2005-05-03 Wisconsin Alumni Research Foundation Method of in vitro differentiation of transplantable neural precursor cells from primate embryonic stem cells
CA2475288C (en) 2002-02-06 2014-09-02 Sanbio, Inc. Method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene
KR20130062359A (ko) 2004-04-12 2013-06-12 산바이오 인코포레이티드 뉴런의 전구 세포 특징들을 나타내는 세포
EP1855700B1 (en) 2005-03-07 2013-10-30 SanBio, Inc. Use of neuronal precursor cells for treatment of central nervous system lesions
WO2008102460A1 (en) 2007-02-23 2008-08-28 Sanbio Inc. Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury
WO2009023251A1 (en) 2007-08-15 2009-02-19 Sanbio, Inc. Methods and compositions for treating neural degeneration
US10702554B2 (en) 2007-12-03 2020-07-07 Sanbio, Inc. Extracellular matrix from pluripotent cells
PL2274430T3 (pl) * 2008-04-30 2017-09-29 Sanbio Inc Komórki regenerujące nerwy ze zmianami w metylacji DNA
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
US8518397B2 (en) * 2009-08-14 2013-08-27 Case Western Reserve University Notch induced natural killer cell generation and therapeutic uses
WO2012154344A1 (en) * 2011-04-06 2012-11-15 Sanbio, Inc. Methods and compositions for modulating peripheral immune function
US20120263681A1 (en) * 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer

Similar Documents

Publication Publication Date Title
Lamers-Kok et al. Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
AU2018262698B2 (en) Expansion of gamma delta T cells, compositions, and methods of use thereof
Zeng et al. Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance
Homann et al. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from μMT/μMT mice
Gillis et al. Long-term culture of human antigen-specific cytotoxic T-cell lines.
Gasper et al. CD4 T-cell memory generation and maintenance
Berglund et al. Advances in umbilical cord blood cell therapy: the present and the future
Harashima et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation
Bézie et al. Advances on CD8+ Treg cells and their potential in transplantation
Kondo et al. Generation and application of human induced‐stem cell memory T cells for adoptive immunotherapy
Mahnke et al. Maintenance of long‐term tumour‐specific T‐cell memory by residual dormant tumour cells
CA2848121C (en) Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
Weber et al. White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy
Zandvliet et al. Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection
Greiner et al. Immunological and clinical impact of manipulated and unmanipulated DLI after allogeneic stem cell transplantation of AML patients
JP2014526244A5 (enExample)
JP2019536461A5 (enExample)
JP2021522839A5 (enExample)
JP2018524987A5 (enExample)
JP2005532803A5 (enExample)
Lee et al. T lymphocyte development and activation in humanized mouse model
JP2020502262A5 (enExample)
O’Reilly et al. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants
Velardi et al. Lymphokine production by T-cell clones after human bone marrow transplantation
Pagliara et al. Cytotoxic T lymphocytes for the treatment of viral infections and posttransplant lymphoproliferative disorders in transplant recipients